Lorelin depot Inj. 3.75mg/7.5mg/11.25mg
Sustained occupation of pituitary GnRH receptors by Leuprorelin results in desensitization and/or downregulation of receptors in the anterior pituitary, thereby suppressing gonadotrophin release and reducing testosterone release by the human testes to castrate levels.
LORELIN DEPOT INJ. 3.75MG/7.5MG/11.25MG
Generic Name: Leuprorelin Acetate
Indications
- Leuprorelin Acetate is used for treating prostatic cancer, endometriosis, premenopausal breast cancer, uterine myoma, and central precocious puberty.
- It also helps manage PCOS, severe PMS, and functional bowel disease, and is being investigated for Alzheimer’s disease.
Strength:
3.75mg, 7.5mg, 11.25mg
Pack Size:
Single-use vial
Dosage Form:
Tablets
Categories:
Pharmaceuticals
Therapeutic Class:
LHRH Analogues